Nanocapsules as carriers for oral peptide delivery

Journal of Controlled Release

Volumn 13, Issue 2-3, 1990, Pages 233-239

  Damge C ^a   Michel, C ^a   Aprahamian, M ^a   Couvreur, P ^b   Devissaguet, J P ^b  

^a INSERM   (France)

^b UNIV PARIS SUD   (France)

Author keywords

drug carrier; insulin; intestinal absorption; nanocapsules; oral administration

Indexed keywords

BUCRILATE; DRUG CARRIER; INSULIN; RADIOISOTOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; INTESTINE ABSORPTION; METHODOLOGY; MICROCAPSULE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SCANNING ELECTRON MICROSCOPY; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION;

EID: 0025091427     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(90)90013-J     Document Type: Article

References (6)

1. Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor
2. Toxicity of polyalkylcyanoacrylate nanoparticles. II. Doxorubicin loaded nanoparticles
3. Degradation of poly-(isobutylcyanoacrylate) nanoparticles
4. Development of a new process for manufacture of polyisobutylcyanoacrylate nanocapsules
5. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier
6. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine